ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,117, issued on April 22, was assigned to SHENZHEN UNIVERSITY (Shenzhen, China).
"Small molecule immune agonists and immune targeting compounds and application thereof" was invented by Guangyi Jin (Guangdong, China), Zhulin Wang (Guangdong, China) and Li Tang (Guangdong, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a series of homologous small molecule immune agonists and novel bifunctional immune targeting compounds having targeting and immune activation functions, which are obtained by coupling the small molecule immune agonists to targeting drugs. The resulting immune targeting compounds are beneficial for enhancing immune activ...